The DOI matches its Crossref record; 58 of the 61 references it cites were found in a registry or an index.
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function
Open accessAbstract
BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1. A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The purified 130-kDa protein was subject to tandem mass spectrometry and the FANCJ gene was cloned and found to consist of 20 exons spanning greater than 180 kb of genomic sequence in chromosome 17q22.”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Furthermore, unlike the classic paradigm for tumor suppressor genes, in which the tumor exclusively lacks the wild-type allele, tumors of individuals who were heterozygous for these two germline FANCJ mutations did not show loss of the corresponding wild-type allele [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“For example, the P47A variant identified in 2001 [8] and shown to disrupt FANCJ enzyme function [56] was found in the controls of a subsequent study and considered to be unrelated to breast cancer [44].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Among the proteins identified was a protein of approximately 130 kDa that failed to interact with a BRCA1, harboring patient mutations within the BRCT motifs (P1749R and M1775R) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Most notably, the protein product had strong homology to the catalytic and nucleotide-binding domains of other members within the DEAH helicase family, including the xeroderma pigmentosum complimenting group D (XPD) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In keeping with this suggestion, two patients with a family history and early-onset breast cancer were identified that had discrete germline sequence changes, P47A and M299I, targeting the helicase domain of FANCJ [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Moreover, the aforementioned P47A mutant had a reduced protein half-life when overexpressed in tissue culture cells [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In particular, overexpression of the helicase-inactive K52R mutant in cells with wild-type FANCJ resulted in the accumulation of unrepaired DNA breaks when analyzed by pulse field electrophoresis [8], as well as reduced homologous recombination following double strand break induction [69].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“BRCA1 clinical mutations target the BRCT region required for FANCJ binding [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Self-citationDynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Self-citation
Research works printed but not linked: 1
- Ma, 1994, Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation, Mol. Cell. Biol., 14, 4126, 10.1128/MCB.14.6.4126 · DOI
Cited by
Sorted by citations
Items 101–200 of 676
Hampton, O. A., den Hollander, P., Miller, C. A., Delgado, D. A., Li, J., Coarfa, C., Harris, R. A., Richards, S., Scherer, S. E., Muzny, D. M., et al. (2008) · Genome Research · doi:10.1101/gr.080259.108 · Cited by 128
Bakovic, M., Fullerton, M. D., & Michel, V. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-006 · Cited by 129
BRCA1 gene: function and deficiency
Takaoka, M., & Miki, Y. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1182-2 · Cited by 133
Identification of genes induced by BRCA1 in breast cancer cells
Atalay, A., Crook, T. J., Öztürk, M., & Yuluğ, I. G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02751-1 · Cited by 126
Kuusisto, K. M., Bebel, A., Vihinen, M., Schleutker, J., & Sallinen, S. (2011) · Breast Cancer Research · doi:10.1186/bcr2832 · Cited by 131
Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Angeli, D., Salvi, S., & Tedaldi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031128 · Cited by 132
Nayak, S. U., Calvo, J. A., Cong, K., Peng, M., Berthiaume, E. A., Jackson, J., Zaino, A. M., Vindigni, A., Hadden, M. K., & Cantor, S. B. (2020) · Science Advances · doi:10.1126/sciadv.aaz7808 · Cited by 119
Self-citationChoreography of recombination proteins during the DNA damage response
Lisby, M., & Rothstein, R. J. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.007 · Cited by 126
Sequence Conservation and Differential Expression of Marek's Disease Virus MicroRNAs
Morgan, R. W., Anderson, A., Bernberg, E. L., Kamboj, S., Huang, E., Lagasse, G., Isaacs, G., Parcells, M. S., Meyers, B. C., Green, P. J., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01722-08 · Cited by 120
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer
Somyajit, K., Subramanya, S., & Nagaraju, G. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq210 · Cited by 122
Lima, Z. S., Ghadamzadeh, M., Arashloo, F. T., Amjad, G., Ebadi, M. R., & Younesi, L. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0725-6 · Cited by 123
The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells
Parish, J. L., Rosa, J., Wang, X., Lahti, J. M., Doxsey, S., & Androphy, E. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03262 · Cited by 117
New complexities for BRCA1 and BRCA2
Kerr, P., & Ashworth, A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00389-x · Cited by 117
Assembly of checkpoint and repair machineries at DNA damage sites
Huen, M. S. Y., & Chen, J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.001 · Cited by 118
Wang, G., Wang, Y., Feng, W., Wang, X., Yang, J. Y., Zhao, Y., Wang, Y., & Liu, Y. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-s2-s22 · Cited by 117
Gupta, R., Sharma, S., Sommers, J. A., Kenny, M. K., Cantor, S. B., & Brosh, R. M. (2007) · Blood · doi:10.1182/blood-2006-11-057273 · Cited by 114
Self-citationHuman single-stranded DNA binding proteins are essential for maintaining genomic stability
Ashton, N. W., Bolderson, E., Cubeddu, L., O'Byrne, K. J., & Richard, D. J. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-9 · Cited by 118
Sommers, J. A., Rawtani, N., Gupta, R., Bugreev, D. V., Mazin, A. V., Cantor, S. B., & Brosh, R. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809019200 · Cited by 112
Self-citationKumaraswamy, E., & Shiekhattar, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-07 · Cited by 110
Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination
Liang, Z., Liang, F., Teng, Y., Chen, X., Liu, J., Longerich, S., Rao, T., Green, A. M., Collins, N. B., Xiong, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.084 · Cited by 104
BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
Aly, A., & Ganesan, S. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq055 · Cited by 116
Self-citationLee, W. T. C., Yin, Y., Morten, M. J., Tonzi, P., Gwo, P. P., Odermatt, D. C., Modesti, M., Cantor, S. B., Gari, K., Huang, T. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22830-9 · Cited by 107
Self-citationHereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1
Cantor, S. B., & Guillemette, S. (2011) · Future Oncology · doi:10.2217/fon.10.191 · Cited by 106
“Among the proteins identified was a protein of approximately 130 kDa that failed to interact with a BRCA1, harboring patient mutations within the BRCT motifs (P1749R and M1775R) [8].”
InfluentialSelf-citationEaston, D. F., Lesueur, F., Decker, B. J., Michailidou, K., Li, J., Allen, J., Luccarini, C., Pooley, K. A., Shah, M., Bolla, M. K., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103529 · Cited by 108
G-quadruplex recognition and remodeling by the FANCJ helicase
Wu, C. G., & Spies, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw574 · Cited by 108
Structure, function and evolution of the XPD family of iron–sulfur-containing 5′→3′ DNA helicases
White, M. F. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370547 · Cited by 104
Peng, Y., Liao, Q., Tan, W., Peng, C., Hu, Z., Chen, Y., Li, Z., Li, J., Zhen, B., Zhu, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09232-8 · Cited by 104
Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance
Anantha, R. W., Simhadri, S. R., Foo, T. K., Miao, S. Y., Liu, J., Shen, Z., Ganesan, S., & Xia, B. (2017) · eLife · doi:10.7554/elife.21350 · Cited by 109
Self-citationMinding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks
Nagaraju, G., & Scully, R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.020 · Cited by 103
FANCJ couples replication past natural fork barriers with maintenance of chromatin structure
Schwab, R. A., Nieminuszczy, J., Shin‐ya, K., & Niedźwiedź, W. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201208009 · Cited by 102
Interaction between the helicases genetically linked to Fanconi anemia group J and Bloom's syndrome
Suhasini, A. N., Rawtani, N., Wu, Y., Sommers, J. A., Sharma, S., Mosedale, G., North, P. S., Cantor, S. B., Hickson, I. D., & Brosh, R. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.362 · Cited by 102
Self-citationThe Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
Monteiro, L. J., Khongkow, P., Kongsema, M., Morris, J. R., Man, C., Weekes, D. B., Koo, C.-Y., Gomes, A., Pinto, P. H., Varghese, V., et al. (2012) · Oncogene · doi:10.1038/onc.2012.491 · Cited by 105
BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains
Magnard, C., Bachelier, R., Vincent, A., Jaquinod, M., Kieffer‐Jaquinod, S., Lenoir, G., & Venezia, N. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205915 · Cited by 102
Characterization of the DNA Damage-inducible Helicase DinG from Escherichia coli
Voloshin, O. N., Vanevski, F., Khil, P. P., & Camerini‐Otero, R. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301188200 · Cited by 102
Youds, J. L., Barber, L. J., Ward, J. D., Collis, S. J., O’Neil, N. J., Boulton, S. J., & Rose, A. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01641-07 · Cited by 100
Welcome the Family of FANCJ-like Helicases to the Block of Genome Stability Maintenance Proteins
Wu, Y., Suhasini, A. N., & Brosh, R. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8580-6 · Cited by 102
Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation
Williams, R. S., & Glover, J. N. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210019200 · Cited by 101
PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
Sy, S. M.-H., Huen, M. S. Y., Zhu, Y., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016717 · Cited by 104
Major cutbacks at chromosome ends
Lansdorp, P. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.004 · Cited by 101
Wong‐Brown, M. W., Nordfors, C., Mossman, D., Pecenpetelovska, G., Avery‐Kiejda, K. A., Talseth‐Palmer, B. A., Bowden, N. A., & Scott, R. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1443-0 · Cited by 104
Pugh, R. A., Honda, M., Leesley, H., Thomas, A., Lin, Y., Nilges, M. J., Cann, I., & Spies, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707064200 · Cited by 99
Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition
Pavlı́ček, A., Noskov, V. N., Kouprina, N., Barrett, J. C., Jurka, J., & Larionov, V. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh301 · Cited by 100
Sridharan, D., Brown, M., Lambert, W. C., McMahon, L., & Lambert, M. W. (2003) · Journal of Cell Science · doi:10.1242/jcs.00294 · Cited by 97
Multifaceted Fanconi Anemia Signaling
Che, R., Zhang, J., Nepal, M. K., Han, B., & Fei, P. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.11.006 · Cited by 97
Structural Basis of BACH1 Phosphopeptide Recognition by BRCA1 Tandem BRCT Domains
Botuyan, M. V., Nominé, Y., Yu, X., Juranić, N., Macura, S. I., Chen, J., & Mer, G. (2004) · Structure · doi:10.1016/j.str.2004.06.002 · Cited by 95
Telomeres: Structures in need of unwinding
Paeschke, K., McDonald, K. R., & Zakian, V. A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.007 · Cited by 102
The DinG Protein from Escherichia coli Is a Structure-specific Helicase
Voloshin, O. N., & Camerini‐Otero, R. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700376200 · Cited by 96
Deciphering the BRCA1 Tumor Suppressor Network
Jiang, Q., & Greenberg, R. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.667931 · Cited by 96
Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk
Figueroa, J. D., Malats, N., Rothman, N., Real, F. X., Silverman, D. T., Kogevinas, M., Chanock, S. J., Yeager, M., Welch, R. A., Dosemeci, M., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm132 · Cited by 95
DNA crosslinking damage and cancer - a tale of friend and foe.
Huang, Y., & Li, L. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.03.01 · Cited by 103
Cyclin D1 Antagonizes BRCA1 Repression of Estrogen Receptor α Activity
Wang, C., Fan, S., Li, Z., Fu, M., Rao, M., Ma, Y., Lisanti, M. P., Albanese, C., Katzenellenbogen, B. S., Kushner, P. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0486 · Cited by 93
De Nicolo, A., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Di Cristofano, C., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0087 · Cited by 91
Self-citationThe UKGPCS Collaborators, T. B. A. O. U. S. S. O. O., Kote-Jarai, Z., Jugurnauth, S., Mulholland, S., Leongamornlert, D. A., Guy, M., Edwards, S., Tymrakiewitcz, M., O'Brien, L., Hall, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604847 · Cited by 91
Green, A. M., & Kupfer, G. M. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.008 · Cited by 90
Esteban-Jurado, C., Vila-Casadesús, M., Garré, P., Lozano, J. J., Přistoupilová, A., Beltrán, S., Muñoz, J., Ocaña, T., Balaguer, F., López‐Cerón, M., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.89 · Cited by 90
Cancer predisposing BARD1 mutations in breast–ovarian cancer families
Ratajska, M., Antoszewska, E., Piskorz, A., Brożek, I., Borg, Å., Kusmierek, H., Biernat, W., & Limon, J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1403-8 · Cited by 96
Targeting the DNA damage response for cancer therapy
Powell, S. N., & Bindra, R. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.011 · Cited by 86
Wang, X., Liu, D., He, D., Suo, S., Xia, X., He, X., Han, J. J., & Zheng, P. (2017) · Genome Research · doi:10.1101/gr.198044.115 · Cited by 91
BACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
Self-citationBiogenesis of Iron–Sulfur Clusters and Their Role in DNA Metabolism
Shi, R., Hou, W., Wang, Z., & Xu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735678 · Cited by 91
Tu, Z., Aird, K. M., Bitler, B. G., Nicodemus, J. P., Beeharry, N., Xia, B., Yen, T. J., & Zhang, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.10.010 · Cited by 94
Distinct functions of BRCA1 and BRCA2 in double-strand break repair
Liu, Y., & West, S. C. (2001) · Breast Cancer Research · doi:10.1186/bcr417 · Cited by 87
Redox Control of the DNA Damage-inducible Protein DinG Helicase Activity via Its Iron-Sulfur Cluster
Ren, B., Duan, X., & Ding, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807943200 · Cited by 87
Du, Y., Gu, S., Zhou, J., Wang, T., Cai, H., MacInnes, M. A., Bradbury, E. M., & Chen, X. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500327-mcp200 · Cited by 86
Caught with One's Zinc Fingers in the Genome Integrity Cookie Jar
Vilas, C. K., Emery, L. E., Denchi, E. L., & Miller, K. M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2017.12.011 · Cited by 87
Molecular Functions of BRCA1 in the DNA Damage Response
Scully, R., Xie, A., & Nagaraju, G. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.842 · Cited by 85
The Spectrum of Genetic Mutations in Breast Cancer
Sheikh, A., Hussain, S. A., Ghori, Q., Naeem, N., Fazil, A., Giri, S., Sathian, B., Mainali, P., & Tamimi, D. M. A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2177 · Cited by 93
Takimoto, R., MacLachlan, T. K., Dicker, D. T., Niitsu, Y., Mori, T., & El‐Deiry, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.65 · Cited by 92
Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3
Alpi, A. F., Chaugule, V. K., & Walden, H. (2016) · Biochemical Journal · doi:10.1042/bcj20160028 · Cited by 81
Multistep mechanism of G-quadruplex resolution during DNA replication
Sato, K., Martin-Pintado, N., Post, H., Altelaar, M., & Knipscheer, P. (2021) · Science Advances · doi:10.1126/sciadv.abf8653 · Cited by 80
Cobain, E. F., Milliron, K. J., & Merajver, S. D. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.10.001 · Cited by 88
Analysis and Interpretation of the Impact of Missense Variants in Cancer
Petrosino, M., Novak, L., Pasquo, A., Chiaraluce, R., Turina, P., Capriotti, E., & Consalvi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115416 · Cited by 81
Thomassen, M., Tan, Q., & Kruse, T. A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-394 · Cited by 78
Honda, M., Park, J., Pugh, R. A., Ha, T., & Spies, M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.003 · Cited by 79
Constitutive Association of BRCA1 and c-Abl and Its ATM-Dependent Disruption after Irradiation
Foray, N., Marot, D., Randrianarison-Huetz, V., Venezia, N. D., Picard, D., Perricaudet, M., Favaudon, V., & Jeggo, P. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4020-4032.2002 · Cited by 79
BRCA1 tumor suppressor network: focusing on its tail
Wang, B. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-6 · Cited by 78
Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia
Brosh, R. M., & Cantor, S. B. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00372 · Cited by 78
Self-citationWu, Q., Paul, A., Su, D., Mehmood, S., Foo, T. K., Ochi, T., Bunting, E. L., Xia, B., Robinson, C. V., Wang, B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.017 · Cited by 80
TIP49b, a Regulator of Activating Transcription Factor 2 Response to Stress and DNA Damage
Cho, S., Bhoumik, A., Broday, L., Ivanov, V. N., Rosenstein, B. S., & Ronai, Z. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8398-8413.2001 · Cited by 77
BET Proteins as Attractive Targets for Cancer Therapeutics
Sarnik, J., Popławski, T., & Tokarz, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011102 · Cited by 78
p53-Dependent BRCA1 Nuclear Export Controls Cellular Susceptibility to DNA Damage
Jiang, J., Yang, E. S.-H., Jiang, G., Nowsheen, S., Wang, H., Wang, T., Wang, Y., Billheimer, D. D., Chakravarthy, A. B., Brown, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3423 · Cited by 76
Unraveling the Fanconi anemia–DNA repair connection
Thompson, L. H. (2005) · Nature Genetics · doi:10.1038/ng0905-921 · Cited by 76
Mannan, A. U., Singh, J., Lakshmikeshava, R., Thota, N., Singh, S., Sowmya, T., Mishra, A., Sinha, A. P., Deshwal, S., Soni, M. R., et al. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.4 · Cited by 74
em BRCA1 em in cancer cell cycle and genomic stability
Jhanwar‐Uniyal, M. (2003) · Frontiers in bioscience · doi:10.2741/1131 · Cited by 76
Epithelial ovarian cancer risk: A review of the current genetic landscape
Flaum, N., Crosbie, E. J., Edmondson, R. J., Smith, M. J., & Evans, D. G. (2019) · Clinical Genetics · doi:10.1111/cge.13566 · Cited by 74
Wu, Y., Sommers, J. A., Suhasini, A. N., Leonard, T., Deakyne, J. S., Mazin, A. V., Shin-ya, K., Kitao, H., & Brosh, R. M. (2010) · Blood · doi:10.1182/blood-2009-11-256016 · Cited by 72
Inherited Mutations in Breast Cancer Genes—Risk and Response
Shuen, A. Y., & Foulkes, W. D. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9213-5 · Cited by 75
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families
Hansen, T. V. O., Jønson, L., Albrechtsen, A., Andersen, M. K., Ejlertsen, B., & Nielsen, F. C. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0088-0 · Cited by 73
Sturdy, A., Naseem, R., & Webb, M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.005 · Cited by 71
Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications
Brandão, A., Paulo, P., & Teixeira, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145036 · Cited by 74
Timeless couples G‐quadruplex detection with processing by DDX11 helicase during DNA replication
Lerner, L. K., Holzer, S., Kilkenny, M. L., Šviković, S., Murat, P., Schiavone, D., Eldridge, C. B., Bittleston, A., Maman, J. D., Branzei, D., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104185 · Cited by 71
Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80
Wei, L., Lan, L., Hong, Z., Yasui, A., Ishioka, C., & Chiba, N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01075-08 · Cited by 78
Cell Cycle-dependent Regulation of a Human DNA Helicase That Localizes in DNA Damage Foci
Gu, J., Xia, X., Yan, P., Liu, H., Podust, V. N., Reynolds, A. B., & Fanning, E. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0227 · Cited by 70
Polyák, K. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00029-4 · Cited by 70
Opposing Roles of FANCJ and HLTF Protect Forks and Restrain Replication during Stress
Peng, M., Cong, K., Panzarino, N. J., Nayak, S. U., Calvo, J. A., Deng, B., Zhu, L. J., Mórocz, M., Hegedűs, L., Haracska, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.065 · Cited by 67
Self-citationRegulation of BRCA1, BRCA2 and BARD1 intracellular trafficking
Henderson, B. R. (2005) · BioEssays · doi:10.1002/bies.20277 · Cited by 74
Molecular Basis of BACH1/FANCJ Recognition by TopBP1 in DNA Replication Checkpoint Control
Leung, C. C. Y., Gong, Z., Chen, J., & Glover, J. N. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189555 · Cited by 62
Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network
Greenberg, R. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0154-8 · Cited by 69
Role of homologous recombination in DNA interstrand crosslink repair
Hinz, J. M. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20577 · Cited by 68
Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia
Savage, S. A., & Walsh, M. F. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.04.002 · Cited by 67
Metadata
- Authors
- Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Livingston, David M.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 105
- Issue
- 1
- Pages
- 149-160
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2109173575
- Cited by
- 674
- References
- 61
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 20 · 2023: 25 · 2022: 17 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 14 · 2017: 20 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 21 · 2012: 35
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007627, T32-HL07627-16)
- National Cancer Institute (P50 CA 89393, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BACH1, BRCA1, protein-protein interaction, DNA double-strand break repair, homologous recombination, germline mutations, early-onset breast cancer, cancer susceptibility genes
- MeSH terms
- Adult, Binding Sites, Boston, Breast Neoplasms, Cell Line, Chromosomes, Human, Pair 17, DNA Repair, DNA Helicases, DNA-Binding Proteins, Female, Genetic Testing, Humans, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, Amino Acid Motifs, Spectrometry, Mass, Electrospray Ionization, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
